Steven H Collis bought $870K of Elevance Health (ELV)
Executed Mar 5, disclosed Mar 6, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Mar 6), the stock returned +6.3% (delay-adjusted); from the execution session (Mar 5), +4.8%. Derived: entry at the session's open, exit at the close 20 sessions later.
Steven H Collis (Executive Chairman) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in Cencora, Inc. (COR). Across 2 priced purchase filings, the average 21-session return was -3.7% from execution and -3.5% from disclosure (delay-adjusted; derived). The largest single filing was $870K of ELV (3,000 sh × $289.84, as filed), executed Mar 5.
Healthcare · Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→